Who Paid My Doc
Optitorque
Device Vascular Access
PDI 04987350700025
General payments
$170,249
Research payments
$599,999
Through program year 2025, $170,249 in general payments and $599,999 in research payments were reported against Optitorque (Vascular Access).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $10,204 | 104 |
| 2024 | General | $17,526 | 125 |
| 2023 | General | $27,566 | 180 |
| 2023 | Research | $100,000 | 1 |
| 2022 | General | $8,342 | 167 |
| 2022 | Research | $199,999 | 2 |
| 2021 | General | $106,611 | 143 |
| 2021 | Research | $300,000 | 2 |
Breakdown
The top 5 of 95 recipients; each share is of general payments naming this product in 2025.
The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
719 general · 5 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.